Product
[11C]MPC6827
1 clinical trial
3 indications
Indication
Neurodegenerative DiseasesIndication
Alzheimer's diseaseIndication
Amyotrophic lateral sclerosisClinical trial
Exploratory Evaluation of [11C]MPC6827 Pharmacokinetics With Positron Emission Tomography (PET)Status: Recruiting, Estimated PCD: 2024-09-01